Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anish Patel

Gastroenterology Fort Sam Houston, TX Doctor of Osteopathy

NPI 1649476466 CMS profile 381697

3551 Roger Brooke Dr, Fort Sam Houston, TX 78234

Open in the dashboard

General payments

$1,318,436

1,360 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$53,065 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Anish Patel of Fort Sam Houston, TX is reported in the CMS Open Payments database as having received $1,318,436 across 1,360 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $53,065 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $430,291 382
2024 General $306,514 292
2023 General $149,733 180
2022 General $219,098 275
2021 General $101,109 82
2020 General $20,954 27
2019 General $90,737 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anish Patel
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Anish Patel were reported at $430,291. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Anish Patel Gastroenterology median Middle half National median
2019 $90,737 $417 $126–$1,100 $163
2020 $20,954 $224 $74–$624 $114
2021 $101,109 $352 $106–$1,054 $132
2022 $219,098 $448 $129–$1,270 $149
2023 $149,733 $533 $150–$1,390 $160
2024 $306,514 $605 $160–$1,606 $164
2025 $430,291 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $381,025 356 payments
  2. Janssen Biotech, Inc. $301,087 255 payments
  3. E.R. Squibb & Sons, L.L.C. $180,410 142 payments
  4. Lilly USA, LLC $149,891 179 payments
  5. AbbVie, Inc. $102,938 135 payments
  6. Janssen Scientific Affairs, LLC $90,519 100 payments
  7. Phathom Pharmaceuticals, Inc. $59,605 60 payments
  8. Daiichi Sankyo Inc. $27,598 29 payments
  9. Pfizer Inc. $14,918 31 payments
  10. Celgene Corporation $5,642 38 payments
  11. Other $4,802 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,049,445 273 payments
  2. Travel and Lodging $208,968 545 payments
  3. Food and Beverage $33,262 527 payments
  4. Consulting Fee $26,740 13 payments
  5. Education $21 2 payments
Products named General payments · program years 2019–2025
  1. ENTYVIO Internal Medicine $322,386 295 payments
  2. STELARA $261,728 254 payments
  3. TREMFYA $240,228 191 payments
  4. ZEPOSIA $154,900 155 payments
  5. SKYRIZI $59,821 50 payments
  6. VOQUEZNA $59,390 57 payments
  7. Entyvio Lower GI $58,520 60 payments
  8. OMVOH $56,370 59 payments
  9. RINVOQ $23,660 34 payments
  10. INJECTAFER $17,140 25 payments
  11. Other $30,438 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,360 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record